InvestorsHub Logo
Followers 14
Posts 396
Boards Moderated 0
Alias Born 12/18/2014

Re: naturalborninvestor post# 682

Wednesday, 12/13/2017 1:45:23 PM

Wednesday, December 13, 2017 1:45:23 PM

Post# of 814
Completely agree with you on a merger or acquisition is the most likely outcome.

BTW, the insider, Dr. Srini Akkaraju, M.D., Ph.D., who acquired almost 1M shares over a week ago, is actually the primary founder of Samsara BioCapital, an Biotech investment firm just filed with SEC in March/2017 with an initial $300M capital. Detailed info can be found via this link
https://www.sec.gov/Archives/edgar/data/1699737/000169973717000003/xslFormDX01/primary_doc.xml

Prior to the crash BioCapital/Dr. Srini Akkaraju had already invested $14M in Versartis (purchased almost 1.5M shares at $12.25). With the doctor's medical background, I think the investor should have a very good knowledge about Somavaratan and decided to put that large amount of money in Versartis. And with the recent purchases, there is a high chance that BioCapital will acquire VSAR.

Also some other Samsara initial investments:
https://www.businesswire.com/news/home/20170421005129/en/Syros-Announces-35-Million-Private-Placement

GLTA